Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
Sara Ng, Clinical and Laboratory Haematologist, Director of Thrombosis and Haemostasis at South Western Sydney Local Health District, shared a post by Anticoagulation Forum on LinkedIn:
“Moving Beyond “Management” to “Stewardship”
Anticoagulants are life-saving, but they remain a top cause of adverse drug events. It’s time to upgrade our approach. The Joint Commission and the National Quality Forum (NQF) have released “Advancing Anticoagulation Stewardship: A Playbook.” This isn’t just about meeting National Patient Safety Goals — It is about building a resilient system that proactively prevents harm.
The 7 Core Elements of a Stewardship Program –
To truly protect our patients, we need to implement these foundational pillars:
1. Leadership Commitment: Securing resources (human, financial, tech) is the non-negotiable first step.
2. Accountability and Expertise: Appoint a single leader responsible for outcomes, supported by clinicians with deep hemostasis expertise.
3. Multidisciplinary Support: Break the silos. Pharmacy, Nursing, Hematology, and IT must work as one unit.
4. Data Tracking: You can’t fix what you don’t measure. Track performance, adverse events, and adherence to guidelines.
5. Systematic Care: Implement evidence-based protocols that are sustainable and standardized across the system.
6. Transitions of Care: The danger zone. Create robust safety nets for patients moving between hospital and home.
7. Education: Ensure every stakeholder—from the prescribing resident to the patient—understands the “why” and “how” of their therapy.
Why This Matters
We often focus on the drug (dosing, monitoring). Stewardship focuses on the system. By addressing barriers like limited data or fragmented communication, we can significantly reduce the risk of bleeding and thrombosis.”
Quoting Anticoagulation Forum‘s post:
“We are proud to have partnered with the National Quality Forum (NQF) on this important resource. It remains a valuable guide for organizations worldwide working to improve patient safety and implement evidence-based stewardship practices.
Explore the report here.”
More posts from Sara Ng on Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch